Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Serum levels of YKL-40 increases in patients with acute myocardial infarction

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Phenotypic variability in Muenke syndrome-observations from five Danish families

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Microvascular dysfunction is associated with plasma osteoprotegerin levels in patients with acute myocardial infarction

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Comparison of patients undergoing enhanced external counterpulsation and spinal cord stimulation for refractory angina pectoris

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Prognostic utility of serum YKL-40 in patients with cervical cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Helicobacter pylori Colonization Drives Urokinase Receptor (uPAR) Expression in Murine Gastric Epithelium During Early Pathogenesis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Angiotensinogen promoter methylation predicts bevacizumab treatment response of patients with recurrent glioblastoma

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Systemic Immune Modulation in Gliomas: Prognostic Value of Plasma IL-6, YKL-40, and Genetic Variation in YKL-40

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Camilla Nøjgaard
  • Nis B Høst
  • Ib Jarle Christensen
  • Steen Hvitfeldt Poulsen
  • Kenneth Egstrup
  • Paul A Price
  • Julia S Johansen
View graph of relations
YKL-40 is secreted by macrophages, including those in atherosclerotic plaques, neutrophils, and vascular smooth muscle cells. Circulating YKL-40 is elevated in patients with inflammation and increased tissue remodeling. The aim was to examine the sequential changes in serum YKL-40 in patients with acute myocardial infarction (AMI), with and without thrombolytic therapy, as compared with patients with stable coronary artery disease (CAD).
Original languageEnglish
JournalCoronary Artery Disease
Volume19
Issue number4
Pages (from-to)257-63
Number of pages7
ISSN0954-6928
DOIs
Publication statusPublished - 2008

    Research areas

  • Adipokines, Adult, Aged, Biological Markers, Case-Control Studies, Female, Fibrinolytic Agents, Glycoproteins, Humans, Lectins, Male, Middle Aged, Myocardial Infarction

ID: 34793341